552 POSTER Targeting MET with XL184 to reverse EGFR...

European Journal of Cancer Supplements 2008 Vol. 6; Iss. 12

552 POSTER Targeting MET with XL184 to reverse EGFR tyrosine kinase inhibitor (TKI) resistance in NSCLC: impact of preclinical studies on clinical trial design

P.A. Janne, M. Wax, J. Leach, J. Engelman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72486-8
File:
PDF, 60 KB
english, 2008
Conversion to is in progress
Conversion to is failed